Avalo Therapeutics, Inc. · NASDAQ:AVTX
Avalo Therapeutics, Inc. shareholders
As of Jun 30, 2026, 123 institutions reported holding Avalo Therapeutics, Inc. Largest: Fidelity, BlackRock and Nantahala Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Avalo Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 5.1M | +2.22M | Aug 13, 2026 | |
| BlackRock | 4.37M | +4.04M | Aug 7, 2026 | |
| Nantahala Capital Management, LLC | 3.72M | +2.49M | Aug 19, 2026 | |
| Deep Track Capital, LP | 3.61M | new | Aug 14, 2026 | |
| Caligan Partners LP | 3.16M | +1.53M | Aug 14, 2026 | |
| TCG Crossover Management, LLC | 3.02M | +2.28M | Aug 14, 2026 | |
| Affinity Asset Advisors, LLC | 2.9M | +1.56M | Aug 13, 2026 | |
| Vanguard | 2.89M | +2.08M | Aug 13, 2026 | |
| State Street | 2.89M | +2.82M | Aug 7, 2026 | |
| Farallon Capital Management, L.L.C. | 2.5M | +1.58M | Aug 14, 2026 |